Dedicated to Finding New Medicines Through Targeting the Ubiquitin Pathway

News Headlines

Progenra receives second immune oncology patent

Progenra publishes findings on novel immune-oncology drug in eBioMedicine

Learn More >


Upcoming Meetings

Progenra President, Dr. Tauseef Butt, has been invited to speak on the role of small molecules in immune oncology at the  Cancer Molecular Therapeutics Research Association (CMTRA) in Burlington, Vermont. July 16-20, 2017.

Learn More >


Business Development

Progenra is seeking industry partnerships for licensing opportunities surrounding the company’s small molecule portfolio Drug Discovery Platform


Learn More >